We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLAB icon
1201
Mesa Laboratories
MLAB
$633M
$6.54M 0.01%
46,438
+1,719
+4% +$314K
EHC icon
1202
Encompass Health
EHC
$12.2B
$6.54M 0.01%
144,570
-25,302
-15% -$1.27M
AVUS icon
1203
Avantis US Equity ETF
AVUS
$14.4B
$6.53M 0.01%
104,738
+4,851
+5% +$333K
RBLX icon
1204
Roblox
RBLX
$27.1B
$6.52M 0.01%
181,987
-28,605
-14% -$1.18M
XMMO icon
1205
Invesco S&P MidCap Momentum ETF
XMMO
$7.61B
$6.52M 0.01%
93,416
+26,478
+40% +$2.03M
P
1206
Everpure Inc
P
$39B
$6.5M 0.01%
237,592
+34,782
+17% +$983K
DINT icon
1207
Davis Select International ETF
DINT
$291M
$6.5M 0.01%
437,082
+358,387
+455% +$5.89M
FNDF icon
1208
Schwab Fundamental International Large Company Index ETF
FNDF
$25.8B
$6.49M 0.01%
257,890
+10,622
+4% +$297K
CLF icon
1209
Cleveland-Cliffs
CLF
$6.93B
$6.47M 0.01%
480,259
-81,213
-14% -$1.35M
FCPT icon
1210
Four Corners Property Trust
FCPT
$2.76B
$6.47M 0.01%
267,370
+40,044
+18% +$1.1M
SYNH
1211
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$6.46M 0.01%
136,989
-18,225
-12% -$1.18M
DEI icon
1212
Douglas Emmett
DEI
$1.99B
$6.45M 0.01%
359,453
+341,325
+1,883% +$7.28M
DXD icon
1213
ProShares UltraShort Dow 30
DXD
$42.6M
$6.42M 0.01%
+109,356
New +$5.34M
HPQ icon
1214
HP
HPQ
$28.6B
$6.4M 0.01%
256,826
-39,399
-13% -$1.21M
GSSC icon
1215
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.11B
$6.4M 0.01%
126,605
+4,331
+4% +$241K
WMS icon
1216
Advanced Drainage Systems
WMS
$11.3B
$6.39M 0.01%
51,369
+9,180
+22% +$1.14M
STPZ icon
1217
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
$6.38M 0.01%
129,167
-69,292
-35% -$3.58M
XYLD icon
1218
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
$6.36M 0.01%
166,790
+22,843
+16% +$967K
BMO icon
1219
Bank of Montreal
BMO
$129B
$6.35M 0.01%
72,454
-882
-1% -$85.3K
LBRDK icon
1220
Liberty Broadband Class C
LBRDK
$5.29B
$6.33M 0.01%
85,766
-147,011
-63% -$15.6M
TWNK
1221
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$6.32M 0.01%
271,794
+1,110
+0.4% +$25.2K
RNG icon
1222
RingCentral
RNG
$5.66B
$6.3M 0.01%
157,585
+482
+0.3% +$23.1K
ZM icon
1223
Zoom
ZM
$32.2B
$6.27M 0.01%
85,143
+711
+0.8% +$67.7K
SAIC icon
1224
Saic
SAIC
$5.35B
$6.26M 0.01%
70,787
-641
-0.9% -$59.7K
RBA icon
1225
RB Global
RBA
$16B
$6.23M 0.01%
99,728
-1,867
-2% -$127K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.